Home > Resources > Mozambique

Mozambique

Building Capacity to Assess Bioequivalence Studies for MNCH Medicines in Mozambique

Building Capacity to Assess Bioequivalence Studies for MNCH Medicines in Mozambique

Publish : 09th Nov 2022

The process of product registration or marketing authorization is a key regulatory function of a national medicines regulatory authority (NMRA) to ensure the safety, quality, and […]

Read More
USAID MTaPS Activity and Product Status Report: Year 4, Quarter 2

USAID MTaPS Activity and Product Status Report: Year 4, Quarter 2

Publish : 29th Apr 2022

This report summarizes USAID MTaPS’ achievements, key challenges, program performance, and adaptation in response to new demands and lessons learned for the January through March 2022 […]

Read More
Protocol for Active Safety Monitoring of a Dolutegravir-Based Antiretroviral Regimen in Mozambique

Protocol for Active Safety Monitoring of a Dolutegravir-Based Antiretroviral Regimen in Mozambique

Publish : 10th Dec 2021

Introduction Dolutegravir-based antiretroviral therapy (ART) is increasingly being used as the preferred first-line regimen for the treatment of HIV in low-income and middle-income countries. The National […]

Read More